SUBSCRIBE
SUBSCRIBE

Postmarket research

Drug Development
Copenhagen University Hospital Study Questions Drugmakers’ Hunt for ‘Good’ Cholesterol Booster
June 4, 2008
 · 
1 min read
Drug Development
Genetic Disorder Drug Helps Reverse Heart Muscle Enlargement, Johns Hopkins University Study Finds
June 2, 2008
 · 
1 min read
Drug Development
Test May Predict Cancer Response To Anemia Drugs, University of Washington Study Finds
June 2, 2008
 · 
1 min read
Drug Development
Anti-Rejection Drug May Boost Diabetes In Kidney Transplant Patients; Those Treated With Wyeth’s Sirolimus Faced Up To 66% Increased Risk Of Disease After Operation, University of British Columbia Study
May 30, 2008
 · 
1 min read
Drug Development
Enzyme May Hold Key To Improved Targeting Of Cancer-Fighting Drugs, Boston College and University of Wisconsin-Madison Study
May 30, 2008
 · 
1 min read
Drug Development
Combination Of Two Novel Anti-Cancer Agents May Help Fight CML Resistant To Current Therapy, Virginia Commonwealth University Study
May 30, 2008
 · 
1 min read
Drug Development
Preventive Treatment Curbs Eczema Flare-Ups, Ludwig-Maximilian Universitat and European Tacrolimus Ointment Study Group Find
May 29, 2008
 · 
1 min read
Drug Development
SALAs Offer No Edge Over Other NSAIDs in Reducing Alzheimer’s Risk, Johns Hopkins University Bloomberg School of Public Health Finds
May 29, 2008
 · 
1 min read
Drug Development
University of Iowa Study Suggests Antidepressants For Stroke Victims
May 28, 2008
 · 
1 min read
Drug Development
University of Cologne Study Shows Benefit Of Statins Before Heart Surgery
May 28, 2008
 · 
1 min read
Load More
PRESS RELEASES
Drug Development
Millennium: The Takeda Oncology Company Reports Positive Velcade Trial Data
December 10, 2012
 · 
7 min read
Drug Development
GlaxoSmithKline: We Conducted Paxil Clinical Trial Program Appropriately
December 7, 2012
 · 
1 min read
Drug Development
AstraZeneca PLC Release: Final Overall Survival Analysis of CONFIRM Shows a 4.1 Month Difference in Median Overall Survival When Using FASLODEX® (fulvestrant) Injection 500 mg Compared With 250 mg.1,2
December 5, 2012
 · 
1 min read
Drug Development
iCeutica Inc. Commences Clinical Program for Metaxalone SoluMatrix™
November 30, 2012
 · 
1 min read
Drug Development
Eli Lilly and Company’s ED Drug, Cialis, Shows Promise in Rare Muscle Disease
November 29, 2012
 · 
1 min read
Drug Development
Digoxin for Atrial Fibrillation Questioned After Deaths, Study Published in the European Heart Journal
November 28, 2012
 · 
1 min read
Drug Development
Novo Nordisk A/S Says New Data Show Victoza Advantage
November 27, 2012
 · 
1 min read
Drug Development
Pacira Pharmaceuticals, Inc. Release: New Data Demonstrate Reduction in Opioid Use, Hospital Cost and Length of Stay With EXPAREL as the Foundation of a Multimodal Regimen
November 20, 2012
 · 
1 min read
Drug Development
Pamlab LLC Release: Metanx® Study Published in the American Journal of Pharmacy Benefits Indicates Treatment Lowers the Risk of Hospitalization and Decreases Disease-Related Costs
November 19, 2012
 · 
4 min read
Drug Development
Roche’s Avastin Shows Mixed Results in Glioblastoma
November 19, 2012
 · 
1 min read
Drug Development
Study Shows Positive Results for Pfizer Inc.'s Lyrica
November 19, 2012
 · 
5 min read
Drug Development
Gilead Sciences, Inc.'s Once-Daily Single Tablet Regimen Stribild™ Maintains High Viral Suppression Through Two Years of Therapy Among Treatment-Naive HIV Patients
November 15, 2012
 · 
1 min read
Drug Development
Gilead Sciences, Inc.'s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients
November 15, 2012
 · 
1 min read
Drug Development
OncoSec Medical Inc. Reports Positive Interim Efficacy Results From Phase IV Study of NeoPulse in Skin Cancer Patients
November 14, 2012
 · 
5 min read
Drug Development
UCB Group Announces Data on Cimzia® (certolizumab pegol) for Patients With Moderate to Severe Rheumatoid Arthritis at American College of Rheumatology 2012 Congress
November 13, 2012
 · 
25 min read
Drug Development
Savient Pharmaceuticals, Inc. Release: New Data Demonstrate KRYSTEXXA®-Treated Refractory Chronic Gout Patients Experienced Significantly Improved Health-Related Quality of Life
November 13, 2012
 · 
11 min read
Drug Development
Bayer Corporation Release: New Canadian-Led Global Study of Bayer’s Xarelto® (rivaroxaban tablet), Initiated for the Secondary Prevention of Cardiovascular Death, Myocardial Infarction and Stroke in Patients With Coronary or Peripheral Artery Disease
November 13, 2012
 · 
8 min read
Drug Development
ViroPharma Incorporated’s Cinryze® (C1 Esterase Inhibitor [Human]) Prophylaxis Study Showed Safety Data of Escalating Doses in Patients With Hereditary Angioedema
November 13, 2012
 · 
8 min read
Drug Development
Bed Bugs Dying After Merck & Co., Inc. Drug Suggests Possible Weapon
November 13, 2012
 · 
1 min read
Drug Development
Horizon Pharma, Inc. Presents Clinical Data Demonstrating RAYOS® (prednisone) Delayed-Release Tablets Reduce Fatigue in Patients With Active Rheumatoid Arthritis
November 12, 2012
 · 
6 min read
Load More